Invesco Dynamic Pharmaceuticals ETF (PJP)

Delayed Data
As of Nov 16
 +0.66 / +0.97%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of pharmaceutical companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 23 U.S. pharmaceuticals companies. These companies are engaged principally in the research- development- manufacture- sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Beaten-Down Pharma ETFs to Buy Post Q3 Results
Nov 06 / - Paid Partner Content


1 month-0.44% 3 years+1.57%
3 months-4.87% 5 years+7.99%
1 year+11.42% Since inception+13.50%
Data through 11/16/2018

Quote Details

Previous close$68.16
Open day’s range67.98 – 69.01
Net asset value (NAV)68.20 (11/15/2018)
Daily volume18,245
Average volume (3 months)35,026
Data as of 8:00pm ET, 11/16/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+7.99%+14.62%
Expense Gross exp ratio0.57%1.28%
Risk 5 year sharpe ratio0.540.77
Net assets$520.6M$3.2B
Average market cap$22.6B$27.2B
Average P/E22.627.5
Dividend / Share--0.31%


FHLC Fidelity MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Invesco S&P 500® Equal Weight Health Ca...


Top 5 Sectors
Portfolio weighting
Healthcare 97.52%
Consumer goods 2.48%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
MRK Merck5.95%
PFE Pfizer5.75%
JNJ Johnson & Johnson5.75%
ABT Abbott Laboratories5.70%
LLY Eli Lilly and Co5.70%
AMGN Amgen5.33%
BMY Bristol-Myers Squibb4.62%
ABBV AbbVie4.46%
PCRX Pacira Pharmaceuticals Inc3.22%
ENDP Endo International PLC3.04%